Recent studies suggest a cross-talk between EGFR and TNFA.52 Another study observed the inhibition of EGFR in lung cancer cells increased TNFA levels as an adaptive response.53 Further scrutinizing the crosstalk between signaling pathways, specifically in response to their environmental signals in essential to avoid failure of novel drug contenders in clinical testing. Here, EGFR is linked to lung carcinoma.